BIMZELX 160 mg/ml ser pré (emb individ) 1 ml
7680685480019
Pharmacode 1125235
CH-68548
L04AC21
07.15.0.
Active substances:
1 / 2
google
Details
- GTIN
- 7680685480019
- Pharmacode
- 1125235
- Product number
- 6854801
- CPT
- -
- Packaging group
- 1
- Unit
- Fertigspritze(n)
- Composition
- bimekizumabum 160 mg, glycinum, natrii acetas trihydricus, acidum aceticum glaciale, polysorbatum 80, aqua ad iniectabile ad solutionem pro 1 ml corresp. natrium 0.45 mg.
Articles (1)
Bimzelx 160 mg, solution injectable en seringue préremplie
Lösung
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
bimekizumabum
|
160.0 MG | Substance | Wirkstoff (Principe actif) |
|
glycinum
|
- | Substance | HNIDK |
|
natrii acetas trihydricus
|
- | Substance | HNIDK |
|
acidum aceticum glaciale
|
- | Substance | HNIDK |
|
polysorbatum 80
|
- | Substance | HNIDK |
|
aqua ad iniectabile
|
- | Substance | HNIDK |
|
natrium
|
0.45 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 1012.55
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/12/2024
Authorization holder
UCB-Pharma SA
1630 Bulle
Authorization information
- Swissmedic authorization number
- 68548
- Drug name
- Bimzelx, solution injectable en seringue préremplie
- Galenic form
- INLFS
- ATC Code
- L04AC21
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 27/10/2022
- Authorization expiration date
- 26/10/2027
- IT number
- 07.15.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- BIMZELX 160 mg/ml ser pré (emb individ) 1 ml
- Description (DE)
- BIMZELX 160 mg/ml Fertspr (Einzelpackung) 1 ml
- Market launch
- 27/10/2022
- Narcotic (BTM)
- No